Director, Real-World Evidence and Epidemiology, Bacterial and Vector Borne Disease Vaccines team

Use Your Power for Purpose

At Pfizer, our Worldwide Medical and Safety colleagues are essential in bridging evidence-based medical decision support with stakeholders to enhance health and treatment outcomes. By developing frameworks to ensure scientific soundness, providing unbiased and medically necessary expertise, and investigating data gaps, we empower healthcare decisions for the safe and appropriate use of medicines for patients. Our mission is straightforward: to support healthcare decisions that lead to better health outcomes. Whether it's creating necessary frameworks, offering unbiased expertise, or closing data gaps, our goal remains the same—empowering healthcare decisions for patient safety and effective treatment. Your innovative leadership will drive the growth of Pfizer's Epidemiology team, fostering a culture of continuous improvement and excellence in patient care.

Scope

This position will assume a global role within the Vaccines Real-World Evidence (RWE) and Epidemiology group, Bacterial and Vector Borne Disease Team, with a focus on pneumococcal conjugate vaccines (PCVs).The director will conduct RWE and epidemiologic studies generating evidence on disease burden, vaccine effectiveness, and vaccine impact to support the pneumococcal franchise. Evidence generated from these studies will be used to inform vaccine recommendations and utilization of licensed PCVs and the development and licensure of next-generation PCVs.

This position requires skills and experience in vaccinology, field epidemiology, infectious disease surveillance, and database studies. The role will involve managing the scientific aspects of complicated long-term projects, interacting with external experts on pneumococcal disease and vaccines, and integrating within a multi-disciplinary team at Pfizer. This position is part of a Vaccines RWE/epidemiology team and will work cross-functionally with collaborators spanning Vaccines Medical teams, Research Units, and the Chief Medical Officer organization (Medical Evidence Generation, Regulatory, Safety, Data Sciences & Analytics, Medical Enablement & Quality) to design, execute, and disseminate results from studies. Example studies include those focused on burden of disease and serotype distribution, as well as studies to evaluate the effectiveness and impact of PCV20 on disease outcomes, including Phase 4 effectiveness studies conducted as post-approval commitments for regulatory agencies. Because the PCV asset resides within Bacterial and Tick-Borne Diseases group, the position may also work on other licensed and pipeline vaccines.

Responsibilities

In this role, you will:

• Conduct epidemiology studies– both field studies involving primary data collection and secondary analyses of real-world data.
• Author and review study protocols, reports, presentations (internally and at scientific conferences), and peer-reviewed manuscripts.
• Provide input to all aspects of study design (e.g., methodology, protocols, analytic plans) for high priority epidemiologic and other scientific studies of importance for pneumococcal vaccine issues such as Vaccine Technical Committee recommendations, schedules, public payer options, relative value compared to other pneumococcal vaccines. 
• Develop innovative approaches to answering global questions on bacterial infectious diseases and vaccines.
• Identify, establish, and maintain relationships with external partners that can collaborate on high-priority global studies.
• Work with internal and external experts in statistics and data analysis to analyze and interpret data from burden of disease and vaccine studies. 
• Be accountable for the collection of epidemiologic and other scientific data necessary for developing vaccine product labels. 

Qualifications

• Advanced degree, including a PhD in Epidemiology or a related discipline and 5+ years of relevant experience in the pharmaceutical, academic and/or medical or public health environments; an MD with 4+ years of relevant experience as previously stated; or an MPH or another relevant Master’s degree and 7+ years of relevant experience previously stated.
• Subject matter expertise in vaccinology and infectious disease epidemiology.
• Strong epidemiological and statistical methods skills used in observational and non-interventional studies.
• At least 5 years of experience in vaccine-related or vaccine-preventable disease related medical/scientific activities including research, clinical development, epidemiological studies, and infectious disease surveillance.
• Prior experience conducting vaccine effectiveness and impact studies strongly preferred. 
• Experience operating within large cross-functional matrices and collaborating with multiple partners.
• Strong technical ex